Arrowhead Pharmaceuticals

• name

  Arrowhead Pharmaceuticals

• homepage url

  arrowheadpharma.com

• country

  United States

• sector

  Healthcare & Health Services

• industry

  Biotechnology

• monthly webtraffic

  15.59K

• monthly webtraffic growth

  3.33%

• stage

  Post-IPO Debt

• raised capital

  400M

Description

Arrowhead Pharmaceuticals focuses on developing therapies using RNA interference technology to target genes associated with diseases, particularly those with significant unmet medical needs. self-described as aiming to have numerous products in clinical trials or on the market by 2025.